Repository logo
 

Significant oligodendrocyte progenitor and microglial cell death is a feature of remyelination following toxin-induced experimental demyelination.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

The extent to which glial cell turnover features in successful remyelination is unclear. In this study, the rat caudal cerebellar peduncle-ethidium bromide lesion model was used to profile oligodendroglial and microglial/macrophage cell death and proliferation dynamics over the course of repair. Lesioned and control tissue was co-labelled with antibody markers for cell identity, proliferation, and apoptosis (TUNEL assay), then imaged at full thickness using confocal microscopy and quantified using custom CellProfiler pipelines. Early remyelination time points were marked by an increased density of total proliferating cells, including oligodendrocyte progenitor cells. Late remyelination time points featured increased TUNEL+ oligodendrocyte progenitor cells: however, most TUNEL+ cells within remyelinating lesions were Iba1+ microglia/macrophages. These results indicate that repairing lesions are characterized by a high degree of glial cell death and suggest that monitoring cell death-related by-products might have clinical value in the setting of remyelination.

Description

Acknowledgements: We thank the technicians at the University of Cambridge Mira Animal Facility and the Wellcome-MRC Cambridge Stem Cell Institute Imaging Facility for their assistance with animal studies and confocal microscopy. Supplementary Figs. S1A and S2 were created with BioRender.com.


Funder: Intramural Research Program; doi: https://doi.org/10.13039/100030692


Funder: National Institute of Neurological Disorders and Stroke; doi: https://doi.org/10.13039/100000065


Funder: Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; doi: https://doi.org/10.13039/100005984


Funder: Canadian Institutes of Health Research; doi: https://doi.org/10.13039/501100000024

Journal Title

Brain Commun

Conference Name

Journal ISSN

2632-1297
2632-1297

Volume Title

7

Publisher

Oxford University Press (OUP)

Rights and licensing

Except where otherwised noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/
Sponsorship
Wellcome Trust (203151/A/16/Z)
Wellcome Trust (203151/Z/16/Z)
Medical Research Council (MC_PC_17230)
D.S.R. and H.G. are supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke (NIH) and the Dr. Miriam and Sheldon G. Adelson Medical Re- search Foundation. H.G. is supported by a Gates-Cambridge Scholarship. P.A. was supported by a Canadian Institute of Health Research (CIHR) Banting Postdoctoral Award while affiliated with the Wellcome-MRC Cambridge Stem Cell Institute at the University of Cambridge. This research was funded in part by the Wellcome Trust [203151/Z/16/Z, 203151/A/16/Z] and the UKRI Medical Research Council [MC_PC_17230]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.